Skip to content
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•37 filings

GPCR

Structure Therapeutics Inc.

Net sales of $828.9K over the last 3 months

2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.

How to read this signal

Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.

JSON example

3-month balance

−$828,904

0 buyers · 2 sellers

12-month purchases

$0.00

0 distinct insiders

12-month sales

$8,674,264

3 distinct insiders

Highlighted alerts

23

12 Rule 10b5-1 trades treated as informational

Buying cluster · 30 days

Fewer than three distinct buyers

CEO/CFO purchases · 12 months

No executive purchases found

Get GPCR insider trades by API

The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.

Get your free API key

GPCR overview: breakout setup, X sentiment and insiders in one page →

Form 4 raw → Raspberry

The value is in what we do not call a signal.

The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.

93
Raw transactions
Everything returned by the filing
35
Voluntary view
P/S trades after deterministic checks
46
Administrative noise
Stored, never alerted
35
10b5-1
Shown as informational
SEC ownership XML facts
Code
F
Shares
10,626
Price
$11.67
Footnotes
6

The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Reflects price per share in Ordinary Shares. 12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II. Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026.

Raspberry interpretation
Informational — no alert

Reason: administrative_code. The trade is reported under a Rule 10b5-1 plan.

Verify in SEC EDGAR

Recent transactions

Voluntary purchases and sales; administrative noise stays hidden.

35 transactions

Coll Crespo Blas

CHIEF MEDICAL OFFICER

Sale 10b5-1
Shares
4,008
Price
$36.15
Value
$144,873
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
100
Price
$47.83
Value
$4,783
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
4,539
Price
$47.20
Value
$214,254
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
1,300
Price
$45.86
Value
$59,623
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
400
Price
$55.05
Value
$22,020
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
519
Price
$54.20
Value
$28,128
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
3,020
Price
$53.13
Value
$160,462
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
839
Price
$50.03
Value
$41,974
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
3,100
Price
$49.29
Value
$152,786
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
16,085
Price
$50.07
Value
$805,376
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
1,367
Price
$50.07
Value
$68,446
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
1,600
Price
$51.71
Value
$82,734
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
6,278
Price
$50.80
Value
$318,895
Open SEC filing

Lin Xichen

CHIEF SCIENTIFIC OFFICER

Sale 10b5-1
Shares
7,878
Price
$49.08
Value
$386,646
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
16,085
Price
$55.07
Value
$885,801
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
1,367
Price
$55.07
Value
$75,281
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
230
Price
$85.04
Value
$19,559
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
6,498
Price
$84.22
Value
$547,262
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
3,880
Price
$83.35
Value
$323,398
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
5,477
Price
$82.10
Value
$449,662
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
20
Price
$85.04
Value
$1,701
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
552
Price
$84.22
Value
$46,489
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
330
Price
$83.35
Value
$27,506
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
465
Price
$82.10
Value
$38,177
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
15,535
Price
$61.45
Value
$954,626
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
16,635
Price
$61.05
Value
$1,015,567
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
5,589
Price
$94.61
Value
$528,775
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
2,159
Price
$94.00
Value
$202,946
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
8,337
Price
$92.52
Value
$771,339
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
1,320
Price
$61.45
Value
$81,114
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
1,414
Price
$61.05
Value
$86,325
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
475
Price
$94.61
Value
$44,940
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
183
Price
$94.00
Value
$17,202
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
709
Price
$92.52
Value
$65,597
Open SEC filing

FMR LLC

10% owner

SaleAlert
Shares
26,310
Price
$17.87
Value
$470,160
Open SEC filing

“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.